“Understanding Triglyceride-Rich Lipoprotein Classes and Cardiovascular Risk: The Need for New Therapies”

https://pubmed.ncbi.nlm.nih.gov/38114852

The review discusses the importance of understanding the different classes of triglyceride-rich lipoproteins and their association with cardiovascular risk, and highlights the need for new therapies that not only lower triglyceride levels but also decrease the number of atherogenic lipoproteins.